Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice (Q35018491)

5 August 2017

1 reference

title

Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice (English)

1 reference

5 August 2017

0 references

13

Bernd C Kieseier

1 reference

5 August 2017

12

Heinz Wiendl

1 reference

5 August 2017

João Carlos Correia de Sa

1

1 reference

5 August 2017

Laura Airas

2

1 reference

5 August 2017

Emmanuel Bartholome

3

1 reference

5 August 2017

Nikolaos Grigoriadis

4

1 reference

5 August 2017

Heinrich Mattle

5

1 reference

5 August 2017

Celia Oreja-Guevara

6

1 reference

5 August 2017

Jonathan O'Riordan

7

1 reference

5 August 2017

Finn Sellebjerg

8

1 reference

5 August 2017

Bruno Stankoff

9

1 reference

5 August 2017

Karl Vass

10

1 reference

5 August 2017

Agata Walczak

11

1 reference

5 August 2017

1 May 2011

1 reference

Therapeutic advances in neurological disorders

5 August 2017

1 reference

5 August 2017

4

1 reference

5 August 2017

3

1 reference

5 August 2017

139-168

1 reference

Symptom cluster and quality of life: preliminary evidence in multiple sclerosis

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Emerging evidence-based physical rehabilitation for multiple sclerosis - towards an inventory of current content across Europe

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Clinical assessment and management of spasticity: a review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Crossover trial of gabapentin and memantine as treatment for acquired nystagmus.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Multiple sclerosis-related central pain disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Pain in multiple sclerosis: prevalence, mechanisms, types and treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Neural control of the lower urinary and gastrointestinal tracts: supraspinal CNS mechanisms.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Neural control of the lower urinary tract: peripheral and spinal mechanisms

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Solifenacin treatment in men with overactive bladder: effects on symptoms and patient-reported outcomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Resistance training improves muscle strength and functional capacity in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Vertigo: epidemiologic aspects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Gamma knife radiosurgery for multiple sclerosis-related trigeminal neuralgia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Neurogenic bowel dysfunction: pathophysiology, clinical manifestations and treatment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Neuromodulation for functional bowel disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Treatment of seizures in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Spasticity, an impairment that is poorly defined and poorly measured

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

A UK consensus on the management of the bladder in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Sexual dysfunction in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Multiple sclerosis beyond EDSS: depression and fatigue

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

A review of psychological correlates of adjustment in patients with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Palliative treatment of dysphonia and dysarthria.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Memantine induces reversible neurologic impairment in patients with MS.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Central vertigo and dizziness: epidemiology, differential diagnosis, and common causes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Correlates of sexual dysfunction in men and women with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Gray matter atrophy in multiple sclerosis: a longitudinal study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Deep brain stimulation and tremor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: a review of the literature

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Seizures in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

An update on acquired nystagmus

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

PDAs as cognitive aids for people with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Pain associated with multiple sclerosis: systematic review and proposed classification

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Spasticity outcome measures in spinal cord injury: psychometric properties and clinical utility

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Botulinum injections for the treatment of bladder symptoms of multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Stereotactic neurosurgery for disabling tremor in multiple sclerosis: thalamotomy or deep brain stimulation?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Review of intervention studies on depression in persons with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Psychosocial interventions in people with multiple sclerosis: a review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Tremor in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Treatment for ataxia in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Amantadine for fatigue in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Sleep and fatigue in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Survey of management of acquired nystagmus in the United Kingdom

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Cognitive impairment and decline in different MS subtypes.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Therapy Insight: bladder dysfunction associated with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Managing specific symptoms in people with multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Randomized controlled trial of an energy conservation course for persons with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

The Goldman Consensus statement on depression in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Epidemiology of typical and atypical craniofacial neuralgias

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Percutaneous retrogasserian glycerol rhizotomy for trigeminal neuralgia: technique and expectations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Exercise and rehabilitation for individuals with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Effects of peripheral cooling on intention tremor in multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

The use of hydrotherapy for the management of spasticity.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

A benefit-risk assessment of baclofen in severe spinal spasticity.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

The role of androgens in female sexual dysfunction.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Inter-rater reliability of the International Cooperative Ataxia Rating Scale (ICARS).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Major depression in multiple sclerosis: a population-based perspective

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Treatments for spasticity and pain in multiple sclerosis: a systematic review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Anti-spasticity agents for multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

The treatment of trigeminal neuralgia in patients with multiple sclerosis using percutaneous radiofrequency rhizotomy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

A randomized controlled study of the acute and chronic effects of cooling therapy for MS.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Benign paroxysmal positioning vertigo in multiple sclerosis: diagnosis, pathophysiology and therapeutic techniques

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

The epidemiology of epilepsy revisited

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Physiotherapy based on the Bobath concept for adults with post-stroke hemiplegia: a review of effectiveness studies.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Minimal neuropsychological assessment of MS patients: a consensus approach

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Clinical effectiveness of oral treatments for spasticity in multiple sclerosis: a systematic review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Cognitive impairments in multiple sclerosis: a review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Pathophysiology of impairment in patients with spasticity and use of stretch as a treatment of spastic hypertonia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Surgical therapy for tremor in multiple sclerosis: an evaluation of outcome measures.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Physiopathology and treatment of fatigue in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Pathophysiology and management of bowel dysfunction in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Controlled randomised crossover trial of the effects of physiotherapy on mobility in chronic multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Percutaneous controlled radiofrequency rhizotomy in the management of patients with trigeminal neuralgia due to multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Sexual dysfunction in multiple sclerosis: a case-control study. I. Frequency and comparison of groups

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Management of neurogenic bladder dysfunction with incontinent ileovesicostomy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Course of depression during the initiation of interferon beta-1a treatment for multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Sensory symptoms of multiple sclerosis: a hidden reservoir of morbidity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Rater reliability of Fahn's tremor rating scale in patients with multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

An open-labelled clinical and electrophysiological study of 3,4 diaminopyridine in the treatment of fatigue in multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Long-term and short-term outcome of multiple sclerosis: a 3-year follow-up study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

The pineal gland, cataplexy, and multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Depression and multiple sclerosis

8 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

8 July 2018

https://api.crossref.org/works/10.1177%2F1756285611403646

Assessing tremor severity

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

The impact of fatigue on patients with multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Treatment of action tremor in multiple sclerosis with isoniazid.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Antiparetic and antispastic effects induced by tizanidine in patients with spastic paresis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Pharmacologic trials in the treatment of cerebellar tremor

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Long-Term Alpha-Adrenergic-Blocking Therapy in Detrusor-Urethra Dyssynergia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Baclofen in the Treatment of Spasticity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

The response to isoniazid of action tremor in multiple sclerosis and its assessment using polarised light goniometry

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Prevalence and prognosis of epilepsy in patients with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Treatment of spasticity with tizanidine in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

A controlled trial of isoniazid therapy for action tremor in multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Amantadine treatment of fatigue associated with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Treatment of cerebellar tremors with carbamazepine: a controlled trial with long-term follow-up

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Colonic and anorectal dysfunction associated with multiple sclerosis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Treatment of spasticity with botulinum toxin: a double-blind study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Hyperbaric oxygen therapy in the treatment of multiple sclerosis. A clinical and electrophysiological study in a 2 year follow-up.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

The management of detrusor instability

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Comparison of dantrolene sodium and diazepam in the treatment of spasticity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions. A double-blind, cross-over study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

The Use of Baclofen in Treatment of Spasticity in Multiple Sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Baclofen for spasticity in multiple sclerosis Double-blind crossover and three-year study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Tremor in multiple sclerosis

8 July 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Regional brain atrophy in primary fatigued patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Relationship of bladder dysfunction to lesion site in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Structure of WM bundles constituting the working memory system in early multiple sclerosis: a quantitative DTI tractography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

A double-blind controlled study of gabapentin and baclofen as treatment for acquired nystagmus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Thalamic stimulation restores defective cerebellocortical inhibition in multiple sclerosis tremor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Self-generated learning in people with multiple sclerosis: an extension of Chiaravalloti and DeLuca (2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Self-generated learning in people with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Endorsement of self-report neurovegetative items of depression is associated with multiple sclerosis disease symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Midbrain lesions and paroxysmal dysarthria in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Short-term cognitive training improves mental efficiency and mood in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Repetitive training of isolated movements improves the outcome of motor rehabilitation of the centrally paretic hand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Dysphagia in multiple sclerosis - prevalence and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Self-generation as a means of maximizing learning in multiple sclerosis: an application of the generation effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Fatigue, mood and quality of life improve in MS patients after progressive resistance training.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Dysphagia in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Multiple sclerosis patients with and without sexual dysfunction: are there any differences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Misoprostol in the treatment of trigeminal neuralgia associated with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

The scope and nature of pain in persons with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Relationship between multiple sclerosis intention tremor severity and lesion load in the brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Stop using the Ashworth Scale for the assessment of spasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Correlation between fatigue and self-esteem in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Inter-rater reliability of the Modified Modified Ashworth Scale in assessing lower limb muscle spasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Fatigue is not associated with raised inflammatory markers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Self-generation to improve learning and memory of functional activities in persons with multiple sclerosis: meal preparation and managing finances.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Efficacy and safety of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Fatigue and sleep disturbance in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Safety, tolerability, and efficacy of orally administered cannabinoids in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Donepezil improved memory in multiple sclerosis in a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Therapy of trigeminal neuralgia secondary to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

High prevalence of restless legs syndrome in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Restless legs syndrome is a common finding in multiple sclerosis and correlates with cervical cord damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Screening for depression among patients with multiple sclerosis: two questions may be enough

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Restless leg syndrome, sleep quality and fatigue in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Epilepsy and multiple sclerosis in Sicily: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Bowel problems and coping strategies in people with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Randomized controlled trial of yoga and exercise in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Voiding dysfunction due to multiple sclerosis: a large scale retrospective analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Lower urinary tract dysfunction in MS: management in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Screening for cognitive impairment in multiple sclerosis using the Symbol digit Modalities Test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Therapy of pain syndromes in multiple sclerosis -- an overview with evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Clinical assessment of spasticity in spinal cord injury: a multidimensional problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Burden and health-related quality of life of Spanish caregivers of persons with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Vibration therapy in multiple sclerosis: a pilot study exploring its effects on tone, muscle force, sensation and functional performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Epilepsy, psychosis, and schizophrenia: clinical and neuropathologic correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Acquired pendular nystagmus in multiple sclerosis: an examiner-blind cross-over treatment study of memantine and gabapentin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Independent contributions of cortical gray matter atrophy and ventricle enlargement for predicting neuropsychological impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

The basal ganglia: a substrate for fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

[Deep brain stimulation for tremor in multiple sclerosis : consensus recommendations of the German Deep Brain Stimulation Association].

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Major depression and quality of life in individuals with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Attenuation of cerebellar tremor with implantation of an intrathecal baclofen pump: the role of γ-aminobutyric acidergic pathways in cerebellar tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Effect of oral antihistamine on local injection site reactions with self-administered glatiramer acetate.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Effects of rivastigmine on memory and cognition in multiple sclerosis.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Sexual dysfunctions in multiple sclerosis.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Overview of spasticity management in multiple sclerosis. Evidence-based management strategies for spasticity treatment in multiple sclerosis.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Use of chronic sacral nerve stimulation in neurological voiding disorders.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Depression in multiple sclerosis: relationship to working memory capacity.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Fatigue in MS is associated with specific clinical features.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Spasticity and the effect of dantrolene sodium.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Tricyclic drugs for depression in children and adolescents.

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3105633

Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis

25 October 2018

1 reference

https://api.crossref.org/works/10.1177%2F1756285611403646

Comparative assessment of Yale Single Question and Beck Depression Inventory Scale in screening for depression in multiple sclerosis

21 January 2018

1 reference

12 December 2020

Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample

1 reference

12 December 2020

Effects of Local Hypothermia on Reflex and Voluntary Activity

1 reference

12 December 2020

[Experience with application of trospium chloride in patients with neurogenic detrusor overactivity]

1 reference

12 December 2020

Relationship between self- and clinically rated spasticity in spinal cord injury

1 reference

12 December 2020

Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group

1 reference

12 December 2020

Symptomatic treatment of multiple sclerosis. Multiple Sclerosis Therapy Consensus Group (MSTCG) of the German Multiple Sclerosis Society

1 reference

12 December 2020

Clinical aspects of fatigue in multiple sclerosis

1 reference

12 December 2020

Erectile dysfunction in multiple sclerosis. Associated neurological and neurophysiological deficits, and treatment of the condition

1 reference

12 December 2020

Advantages and risks of ileovesicostomy for the management of neuropathic bladder

1 reference

12 December 2020

The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis

1 reference

12 December 2020

A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group

1 reference

12 December 2020

Fatigue in Multiple Sclerosis

1 reference

12 December 2020

4-aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safety

1 reference

12 December 2020

Multiple sclerosis: the relationship among self-esteem, social support, and coping behavior

1 reference

12 December 2020

The effect of dantrolene sodium on spasticity in multiple sclerosis

1 reference

12 December 2020

A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis

1 reference

12 December 2020

Seizures in patients with multiple sclerosis seen at Mayo Clinic, Rochester, Minn, 1990-1998

1 reference

12 December 2020

Disturbances of swallowing and esophageal motility in patients with multiple sclerosis

1 reference

12 December 2020

Seizures in multiple sclerosis

1 reference

12 December 2020

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients: results of a randomized, double-blind, placebo-controlled, crossover trial

1 reference

12 December 2020

One question as a screening instrument for depression in people with multiple sclerosis

1 reference

12 December 2020

Fatigue in multiple sclerosis and its relationship to depression and neurologic disability

1 reference

12 December 2020

Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis

1 reference

12 December 2020

[Local ice application in therapy of kinetic limb ataxia. Clinical assessment of positive treatment effects in patients with multiple sclerosis]

1 reference

12 December 2020

Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis

1 reference

12 December 2020

Incidence of seizures in patients with multiple sclerosis: a population-based study

1 reference

12 December 2020

PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS

1 reference

12 December 2020

Risk of epilepsy in patients with multiple sclerosis: a population-based study in Iceland

1 reference

12 December 2020

Urodynamic pattern changes in multiple sclerosis

1 reference

12 December 2020

Treatment of refractory urge urinary incontinence with sacral spinal nerve stimulation in multiple sclerosis patients

1 reference

12 December 2020

Dysphagia and nutritional status in multiple sclerosis

1 reference

12 December 2020

A study of tremor in multiple sclerosis

1 reference

12 December 2020

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome

1 reference

12 December 2020

Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression

1 reference

12 December 2020

[Ocular motor disorders in multiple sclerosis]

1 reference

12 December 2020

Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue

1 reference

12 December 2020

Epilepsy and multiple sclerosis: Increased risk among progressive forms

1 reference

12 December 2020

Swallowing abnormalities in multiple sclerosis: correlation between videofluoroscopy and subjective symptoms

1 reference

12 December 2020

Fatigue in MS is related to sympathetic vasomotor dysfunction

1 reference

12 December 2020

Intrathecal baclofen for severe spinal spasticity

1 reference

12 December 2020

Treatment of multiple sclerosis with hyperbaric oxygen. Results of a national registry

1 reference

12 December 2020

Elevated suicide risk among patients with multiple sclerosis in Sweden

1 reference

12 December 2020

Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo

1 reference

12 December 2020

Multi-centre, double-blind trial of a novel antispastic agent, tizanidine, in spasticity associated with multiple sclerosis

1 reference

12 December 2020

The social impact of multiple sclerosis--a study of 305 patients and their relatives

1 reference

12 December 2020

Prevalence of bowel dysfunction in multiple sclerosis. A population survey

1 reference

12 December 2020

4-Aminopyridine induces functional improvement in multiple sclerosis patients: a neurophysiological study

1 reference

12 December 2020

Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial

1 reference

12 December 2020

Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia

1 reference

12 December 2020

Amantadine therapy for fatigue in multiple sclerosis

1 reference

12 December 2020

FES cycling reduces spastic muscle tone in a patient with multiple sclerosis

1 reference

12 December 2020

Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning

1 reference

12 December 2020

Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction

1 reference

12 December 2020

Screening for major depression in the early stages of multiple sclerosis

1 reference

12 December 2020

Dizziness in primary care. Results from the National Ambulatory Medical Care Survey

1 reference

12 December 2020

Research on a technic for measurement of spasticity

1 reference

12 December 2020

Interrater reliability of a modified Ashworth scale of muscle spasticity

1 reference

12 December 2020

Identifiers

DOI

10.1177/1756285611403646

1 reference

5 August 2017

1 reference

5 August 2017

1 reference